Recombitek C3 (rDAP) Vaccine, 1 ml x 25 doses

NOTICE: This item requires Express shipping due to the perishable nature of this product. Express orders are shipped Monday-Wednesday. Cannot be shipped to a P.O. box. Product can only be shipped to the continental US.

Core Protection Against Distemper, Adenovirus, and Parvovirus

Product Description

Recombitek C3 (rDAP) is a core canine vaccine for healthy dogs 6 weeks and older. After reconstitution, one 1 mL helps vaccinate against canine distemper virus, canine adenovirus (types 1 and 2), and canine parvovirus when used according to label directions. The formulation combines a recombinant canarypox-vectored distemper component with modified live adenovirus and parvovirus, plus sterile diluent.

Benefits

• Core Coverage: Helps vaccinate against distemper, adenovirus types 1/2, and parvovirus.
• Early Start: Indicated for healthy dogs beginning at 6 weeks of age.
• Recombinant Distemper: Uses canarypox-vectored distemper component to support immune response.
• Flexible Injection: Administered as a 1 mL dose subcutaneously or intramuscularly.
• Multi-Dose Pack: Supplied as 25 doses with sterile diluent for reconstitution.

Ingredients

Active ingredients: Recombinant canarypox vector (canine distemper virus HA & F glycoproteins).
Modified live canine adenovirus type 2.
Modified live canine parvovirus.
Inactive Ingredients: Sterile water diluent and Gentamicin

How to Use

Dosage & Administration Instructions

• Reconstitute First: Aseptically rehydrate the lyophilized vial with the accompanying sterile diluent.
• Mix Well: Agitate after rehydration to ensure uniform suspension before dosing.
• Give 1 mL: Administer one 1 mL dose to healthy dogs.
• Route Options: Inject subcutaneously or intramuscularly using sterile equipment and technique.
• Primary Booster: Revaccinate with a second 1 mL dose 2-3 weeks later.

Additional Information

Precautions

• Use immediately: Use entire contents right after reconstitution; do not store mixed product.
• Reaction awareness: Rare lethargy, fever, injection-site pain/swelling, or hypersensitivity may occur.
• Pregnancy notes: Product has not been tested in pregnant animals; consult a veterinarian.
• Human exposure: If exposure occurs, contact a physician; inactivate unused contents before disposal.
• Handling limits: Store 2-8°C; don’t chemically sterilize needles; don’t mix with other products.

Shipping & Returns

We offer ground, express, priority, and international delivery; see our shipping policy for details.

For return instructions or product concerns, please refer to our detailed refund policy.

Frequently Asked Questions

Q1: What does Recombitek C3 (rDAP) vaccinate dogs against?

Ans: Recombitek C3 is indicated for vaccinating healthy dogs 6 weeks and older against canine distemper virus, canine adenovirus types 1 and 2, and canine parvovirus. Consult a veterinarian to create a comprehensive vaccination schedule tailored to your dog's needs.

Q2:  What type of vaccine components are in Recombitek C3?

Ans: Recombitek C3 includes a recombinant canarypox vector for the distemper component, as well as modified live adenovirus type 2 and parvovirus. Together, the antigens are intended to stimulate protective immunity in healthy dogs after proper reconstitution and administration.

Q3: How is Recombitek C3 prepared and administered?

Ans: Rehydrate the lyophilized vaccine aseptically using the accompanying sterile diluent, then agitate to mix thoroughly. Administer 1 mL as a single dose either subcutaneously or intramuscularly into a healthy dog, using sterile technique and clean equipment throughout.

Q4: What is the initial booster timing for Recombitek C3?

Ans: For a primary vaccination series, administer a second 1 mL dose 2 to 3 weeks after the first dose. Puppies may need additional boosters because maternal antibodies can interfere; your veterinarian should advise the best revaccination frequency.

Q5: How should Recombitek C3 be stored and handled?

Ans: After reconstitution, the entire contents should be used immediately for best potency. Keep vials refrigerated at 2-8°C (35-46°F) and avoid freezing. Do not sterilize syringes and needles with chemicals, as it may affect vaccine viability.

Q6: What side effects can occur after vaccination?

Ans: Some dogs may experience transient lethargy, fever, or pain and swelling at the injection site after vaccination. In rare cases, inflammatory or hypersensitivity reactions can occur; a veterinarian may direct treatment with antihistamines, anti-inflammatories, and/or epinephrine.

Q7: Can Recombitek C3 be used in pregnant dogs?

Ans: Recombitek C3 has not been tested in pregnant animals. If vaccination is being considered for a pregnant or breeding dog, consult a veterinarian to weigh risks and benefits and to select an appropriate timing and product choice.

Q8: Does Recombitek C3 contain preservatives?

Ans: The vaccine contains gentamicin as a preservative. A veterinarian should assess dogs with a known sensitivity to aminoglycosides before vaccination, and owners should monitor carefully for any unexpected reactions or injection-site changes after administration.

Q9: What should be done if a person is exposed to the vaccine?

Ans: In case of human exposure, contact a physician promptly. Unused contents should be inactivated before disposal. Recombitek C3 is labeled for animal use only and is sold exclusively to veterinarians; therefore, handling should follow the guidance of a professional.